Source:http://linkedlifedata.com/resource/pubmed/id/21609895
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2011-6-7
|
pubmed:abstractText |
Primary human epithelial renal cells of normal (HRE), paratumoral (pTEC) and tumoral (RCC) origin display important differences, concerning the expression and biological effects of the IL-15/IL-15R system that deeply influences the evolution of the tumour microenvironment. A major distinguishing feature is represented in RCC and pTEC by the loss of the ?c chain leading to the assembly of a IL-15R?? heterodimer that in response to physiologic concentrations of IL-15 initiates the process of their epithelial-mesenchymal transition (EMT). In contrast, this treatment in HRE cells, which display the IL-15R???c heterotrimer, causes opposite effects inhibiting their drift towards EMT. Thus, IL-15 at physiologic concentrations displays novel functions acting as a major regulator of renal epithelial homeostasis. As second distinguishing feature, RCC and pTEC but not HRE cells express a trans-membrane-bound IL-15 (tmb-IL-15) able to deliver a reverse signal in response to the soluble IL-15R? chain inducing their EMT. In conclusion, comparison of primary normal (HRE) to primary pathological cells (pTEC and RCC) highlights two major issues: (1) IL-15 is a major regulator of epithelial homeostasis; (2) "apparently normal" pTEC cells, could contribute to organize a generalized "pre-neoplastic" environment committed to favour tumour progression.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cadherins,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin Receptor Common gamma...,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-15,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-15 Receptor alpha...,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2 Receptor beta Subunit,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Vimentin
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1769-6917
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
98
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
32-9
|
pubmed:meshHeading |
pubmed-meshheading:21609895-Cadherins,
pubmed-meshheading:21609895-Carcinoma, Renal Cell,
pubmed-meshheading:21609895-Cell Communication,
pubmed-meshheading:21609895-Epithelial Cells,
pubmed-meshheading:21609895-Epithelial-Mesenchymal Transition,
pubmed-meshheading:21609895-Humans,
pubmed-meshheading:21609895-Interleukin Receptor Common gamma Subunit,
pubmed-meshheading:21609895-Interleukin-15,
pubmed-meshheading:21609895-Interleukin-15 Receptor alpha Subunit,
pubmed-meshheading:21609895-Interleukin-2 Receptor beta Subunit,
pubmed-meshheading:21609895-Kidney,
pubmed-meshheading:21609895-Kidney Neoplasms,
pubmed-meshheading:21609895-Recombinant Proteins,
pubmed-meshheading:21609895-Tumor Microenvironment,
pubmed-meshheading:21609895-Vimentin
|
pubmed:year |
2011
|
pubmed:articleTitle |
Interleukin-15 is a major regulator of the cell-microenvironment interactions in human renal cancer.
|
pubmed:affiliation |
Hôpital Paul-Brousse, université de Paris-Sud, Inserm UMR 1014, 14, avenue Paul-Vaillant-Couturier, 94807 Villejuif Cedex, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|